Sponsor or institution

Clinical trials and research at New Approaches to Neuroblastoma Therapy Consortium

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• STING: sequential temozolomide, irinotecan, donor NK cells, and dinutuximab for neuroblastoma

  This will test whether adding donor TGF‑beta‑imprinted NK cells to dinutuximab plus temozolomide, irinotecan, and GM‑CSF helps children and young adults with relapsed or refractory high‑risk neuroblastoma.

  Recruiting at 8 sites Phase 2 New Approaches to Neuroblastoma Therapy Consortium · Los Angeles, California and 12 other locations · NCT06450041

• Study of neuroblastoma cell characteristics and treatment outcomes

  This study is collecting samples from children with high-risk neuroblastoma to learn more about the disease and find better ways to treat it.

  Recruiting at 13 sites New Approaches to Neuroblastoma Therapy Consortium · Los Angeles, California and 16 other locations · NCT01587300

Quick answers

How many clinical trials run by New Approaches to Neuroblastoma Therapy Consortium are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →